Healthcare and pharmaceutical organizations depend on robust and efficient supply chains to ensure continuous access to essential medicines and medical products. Recent global disruptions have exposed critical vulnerabilities in conventional supply chain structures, underscoring the urgent need for strategic transformation. This study investigates the influence of supply chain resilience, risk management practices, and collaborative strategies on operational efficiency within healthcare and pharmaceutical organizations. A quantitative research approach was employed, with primary data collected from 180 supply chain professionals; this sample also served as a pilot study to validate the research instrument. Reliability and validity were established through appropriate statistical tests. Data were analyzed using descriptive statistics, correlation analysis, and multiple regression techniques. The findings reveal that resilience-focused supply chain strategies have a significant positive impact on operational efficiency and overall performance. The study offers empirical evidence and practical insights to support the development of more resilient healthcare and pharmaceutical supply chains in increasingly uncertain and dynamic environments.
Krishna et al. (Thu,) studied this question.